TY - JOUR
T1 - High-order epistasis in catalytic power of dihydrofolate reductase gives rise to a rugged fitness landscape in the presence of trimethoprim selection
AU - Tamer, Yusuf Talha
AU - Gaszek, Ilona K.
AU - Abdizadeh, Haleh
AU - Batur, Tugce Altinusak
AU - Reynolds, Kimberly A.
AU - Atilgan, Ali Rana
AU - Atilgan, Canan
AU - Toprak, Erdal
N1 - Funding Information:
We would like to thank Shimon Bershtein, Roy Kishony and Kishony Lab members for their generous technical help. We also want to thank Frank J. Poelwijk for the fruitful discussions about calculation of high-order epistasis. This work was supported by the UTSW Endowed Scholars Program (E.T.), National Institutes of Health grant R01GM125748 (E.T.), EMBO Installation Grant 2552 (E.T.), Human Frontier Science Program grant RGP0042/2013 (E.T.), and the Scientific and Technological Research Council of Turkey grant 114Z527 (C.A.).
Publisher Copyright:
© The Author(s) 2019.
PY - 2019/7/1
Y1 - 2019/7/1
N2 - Evolutionary fitness landscapes of several antibiotic target proteins have been comprehensively mapped showing strong high-order epistasis between mutations, but understanding these effects at the biochemical and structural levels remained open. Here, we carried out an extensive experimental and computational study to quantitatively understand the evolutionary dynamics of Escherichia coli dihydrofolate reductase (DHFR) enzyme in the presence of trimethoprim-induced selection. To facilitate this, we developed a new in vitro assay for rapidly characterizing DHFR steady-state kinetics. Biochemical and structural characterization of resistance-conferring mutations targeting a total of ten residues spanning the substrate binding pocket of DHFR revealed distinct changes in the catalytic efficiencies of mutated DHFR enzymes. Next, we measured biochemical parameters (Km, Ki, and kcat) for a mutant library carrying all possible combinations of six resistance-conferring DHFR mutations and quantified epistatic interactions between them. We found that the high-order epistasis in catalytic power of DHFR (kcat and Km) creates a rugged fitness landscape under trimethoprim selection. Taken together, our data provide a concrete illustration of how epistatic coupling at the level of biochemical parameters can give rise to complex fitness landscapes, and suggest new strategies for developing mutant specific inhibitors.
AB - Evolutionary fitness landscapes of several antibiotic target proteins have been comprehensively mapped showing strong high-order epistasis between mutations, but understanding these effects at the biochemical and structural levels remained open. Here, we carried out an extensive experimental and computational study to quantitatively understand the evolutionary dynamics of Escherichia coli dihydrofolate reductase (DHFR) enzyme in the presence of trimethoprim-induced selection. To facilitate this, we developed a new in vitro assay for rapidly characterizing DHFR steady-state kinetics. Biochemical and structural characterization of resistance-conferring mutations targeting a total of ten residues spanning the substrate binding pocket of DHFR revealed distinct changes in the catalytic efficiencies of mutated DHFR enzymes. Next, we measured biochemical parameters (Km, Ki, and kcat) for a mutant library carrying all possible combinations of six resistance-conferring DHFR mutations and quantified epistatic interactions between them. We found that the high-order epistasis in catalytic power of DHFR (kcat and Km) creates a rugged fitness landscape under trimethoprim selection. Taken together, our data provide a concrete illustration of how epistatic coupling at the level of biochemical parameters can give rise to complex fitness landscapes, and suggest new strategies for developing mutant specific inhibitors.
KW - Antibiotic resistance
KW - Epistasis
KW - Experimental evolution
KW - Molecular evolution
KW - Protein evolution
UR - http://www.scopus.com/inward/record.url?scp=85068243996&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85068243996&partnerID=8YFLogxK
U2 - 10.1093/molbev/msz086
DO - 10.1093/molbev/msz086
M3 - Article
C2 - 30982891
AN - SCOPUS:85068243996
SN - 0737-4038
VL - 36
SP - 1533
EP - 1550
JO - Molecular Biology and Evolution
JF - Molecular Biology and Evolution
IS - 7
ER -